Pernix Therapeutics Soars 75% Following Report of 5.8% Stake by Point 72

Loading...
Loading...
Shares of
Pernix Therapeutics Holdings IncPTX
, a nano-cap specialty pharmaceutical company that focuses on products that addresses unmet medical needs, soared higher by more than 75 percent early Monday morning. Investors and traders were reacting to
Point72 Asset Management's disclosure on Friday that has acquired a 5.8 percent stake in the company. Point72 Asset Management is a notable asset manager founded by billionaire investor Steven Cohen.
Posted In: NewsPernix TherapeuticsPoint72 Asset ManagementSteven CohenTherapeutics Stocks
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...